PR N°C3416C STMicroelectronics to propose the reappointment of Jean-Marc Chery as President & CEO Geneva, October 13, 2026 – STMicroelectronics (NYSE: STM) announced today that its Supervisory Board has asked Jean-Marc Chery, ST’s President and CEO, to be available for a reappointment in his current role for an additional year. Jean-Marc Chery has accepted the proposal. The Supervisory Board will therefore propose to the shareholders adoption at the Company’s 2027 Annual General Meeting of Shareholders, the reappointment for a one-year term of Jean-Marc Chery, as Chairman of the Managing Board and the Company’s President and Chief Executive Officer. Mr. Chery’s leadership and vision, combined with a strong focus on execution, have provided ST with a clear strategic course supporting the continued development of ST’s...

OSLO, Norway (13 October 2026) – TGS, a global provider of energy data and intelligence, in joint venture with SLB, announces the Pelotas Sul Phase 2 multi-client 3D survey offshore southern Brazil. The survey will cover approximately 11,200 square kilometers. A Ramform Titan-class vessel is scheduled to commence data acquisition in October 2026, with completion in Q2/Q3 2027. Building on Pelotas Sul Phase 1, acquired earlier this year, the new survey will further expand TGS’ high-quality 3D seismic coverage in a frontier basin that continues to attract industry interest. The Pelotas Basin is supported by geological analogs along the conjugate margin and de-risked by discoveries in Namibia. The basin offers a broad range of underexplored play concepts, including turbidite systems, deep-water channels, and stratigraphic and structural...

AS LHV Group invites investors and other interested parties to attend the webinar presenting AS LHV Group’s unaudited financial results for the third quarter of 2026, on 20 October at 11:00 EET. The presentation will be held in English. The presentation will be hosted by:Mihkel Torim – Chief Executive Officer, LHV Group Meelis Paakspuu – Chief Financial Officer, LHV GroupTo participate in the webinar, please register in advance using the link here. During the webinar, participants will also have the opportunity to ask questions, which will be answered at the end of the session. If you are joining the webinar by phone, please download the Microsoft Teams app. The webinar will be recorded and made available on the LHV Group website at https://investor.lhv.ee/en and on LHV’s YouTube channel. LHV Group is the...

Melexis NV (Euronext Brussels: MELE)Press release – Regulated informationTessenderlo (BE), 13 October 2026 – 07:00 CET Disclosure of transparency notification (article 14, first paragraph, of the Law of 2 May 2007) Notification by Invesco Ltd. of 8 October 2026 Summary of the notification Melexis NV has received a transparency notification from Invesco Ltd. dated 8 October 2026, which indicates that, as a result of the disposal of shares on 1 October 2026, it now holds less than 5% of the voting rights of Melexis NV. Invesco Ltd. has thus crossed the 5% threshold (downward). Content of the notification The notification, dated 8 October 2026, contains the following information:Categories of notification Results of the received formReason for the notification Acquisition or disposal of voting securities or voting rights;Downward crossing...

Press release Nokia to sell Enterprise Campus Edge business to AURELIUSDeal supports Nokia’s strategy to focus capital where the company can differentiate and create long-term value. Planned transaction will provide ECE with greater independence and agility, helping it respond more quickly to customer needs and accelerate the digitalization and transformation of industrial operations.13 October 2026 Espoo, Finland – Nokia today announced that it has signed a definitive agreement regarding the proposed acquisition by AURELIUS of Nokia Enterprise Campus Edge (ECE) business. The planned transaction is expected to close in the first half of 2027, subject to customary closing conditions. As a standalone business under AURELIUS’s ownership, ECE is expected to benefit from greater independence and a dedicated strategic focus, helping...

CSG (‘the Group’), a global industrial and defence group, today announces its entry into the space sector through the acquisition of shares resulting in a 9.5% equity position in MDA Space Ltd. (‘MDA Space’), making CSG MDA Space’s largest shareholder at this time. MDA Space is one of the largest space companies and a leading global provider of advanced space technologies and services listed on the Toronto Stock Exchange and New York Stock Exchange.  Defence and space are tightly interconnected. Developing capabilities in space is a natural extension of the Group’s existing activities in defence and aerospace. The global space economy is projected to triple and reach $1.8 trillion[1] by 2035, with commitments signalling a clear, multi-year acceleration in in-space investment, including approximately $74 billion[2] in global government...

BEIJING, Oct. 12, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has approved the registrational Phase III study of the Company’s novel BCL2 inhibitor mesutoclax (ICP-248) in combination with orelabrutinib for the treatment of patients with marginal zone lymphoma (MZL) who have received at least one prior therapy. This marks the fifth registrational clinical trial initiated for mesutoclax. Mesutoclax is a novel, oral BCL2 inhibitor developed by InnoCare that can exert anti-tumor activity by selectively inhibiting BCL2 and restoring the normal apoptosis process in cancer cells. Mesutoclax is accelerating...

LISLE, Ill, Oct. 12, 2026 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) will release its earnings for the third quarter 2026 at approximately 8:00 a.m. (ET) on Tuesday, October 27, 2026. A conference call to discuss the results of the third quarter of 2026 with management is scheduled for Tuesday, October 27, 2026, at 10:00 a.m. (ET). The conference call can be accessed by registering online at CTS Corporation Q3 2026 Earnings Call. Analysts can access the call using the registration link Analyst registration, at which time registrants will receive dial-in information as well as a conference ID. A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at https://investors.ctscorp.com/news-events/events-and-presentations/ where it will...

A showcase of the Group’s global reach, technological innovation, and sustainability initiatives WUHU, China, Oct. 12, 2026 (GLOBE NEWSWIRE) — Under the theme “Eco-Tech For Our Future Life,” the 2026 Chery International User Summit will take place in Wuhu from October 18 to 24. Against the backdrop of a rapidly evolving global automotive industry, the summit will showcase Chery Group’s global presence, technological breakthroughs, and sustainability initiatives. On October 21, LUXEED, the Group’s intelligent luxury brand, will make its global debut under the theme “INTELLIGENCE, ENLIGHTENED.”Building on Global Strength to Drive International Growth With years of experience in global markets, Chery Group has surpassed 20 million vehicles in cumulative global sales and established a mature business network spanning major markets...

TEL AVIV, Israel, Oct. 12, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will host an R&D Day on Wednesday, November 11, 2026. At the R&D Day, Teva’s leadership will discuss its R&D pipeline, its near-term value-creation potential over the next five years, and Teva’s ongoing transformation into an innovative biopharma company through the Pivot to Growth strategy. The event will take place in New York, N.Y. Presentations will begin at 8:30 a.m. Eastern Time and are expected to conclude at 12:30 p.m. Eastern Time. Due to limited capacity, in-person attendance is by invitation only. Analysts and institutional investors invited to attend will receive separate registration instructions. For questions regarding the event, please contact Teva’s Investor Relations...